TrialStroke2017

ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.

Alla Guekht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.